AXL and glioblastoma: Overall, these findings suggest that quercetin has potential as an anticancer agent for glioblastoma treatment, potentially improving the cancer microenvironment and offering a new therapeutic strategy for managing glioblastoma by targeting the Axl/IL-6/STAT3 signaling pathway [202].